N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide
TL;DR: N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide (CAS 900900-72-3) is a chemical compound with molecular formula C20H21N3O4 and molecular weight 367.15 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-(3-imidazol-1-ylpropyl)-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide
Also Known As: N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide, N-(3-imidazol-1-ylpropyl)-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide, N-[3-(1H-imidazol-1-yl)propyl]-2-[(4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy]acetamide
| Molecular Formula | C20H21N3O4 |
|---|---|
| Molecular Weight | 367.15 g/mol |
| LogP | 2.0635 |
| Topological Polar Surface Area | 86.36 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Exact Mass | 367.1532 |
| Heavy Atoms | 27 |
| Complexity | 1007.9839 |
Chemical Identifiers
| CAS Number | 900900-72-3 |
|---|---|
| SMILES | C1CC2=C(C1)C(=O)OC3=C2C=CC(=C3)OCC(=O)NCCCN4C=CN=C4 |
Product Overview
N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide (CAS 900900-72-3), with molecular formula C20H21N3O4 and molecular weight 367.15 g/mol. IUPAC: N-(3-imidazol-1-ylpropyl)-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide.
Chemical Property Profile of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide
Property Insights of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide
The XLogP value of 2.0635 suggests moderate lipophilicity, balancing water solubility and membrane permeability for N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide. The TPSA of 86.36 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide. Following Lipinski's Rule of Five, N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide has 1 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide?
The CAS number of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide is 900900-72-3.
What is the molecular formula of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide?
The molecular formula of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide is C20H21N3O4.
What is the molecular weight of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide?
The molecular weight of N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide is 367.15 g/mol.
Where can I buy N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide?
You can request a quote for N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide?
Yes, KEHONG BIO provides custom synthesis services for N-(3-(1H-imidazol-1-yl)propyl)-2-((4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy)acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.